Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France

Evaluating the cost-effectiveness of afatinib after platinum-based therapy for the treatment of squamous non-small-cell lung cancer in France

Maud Pignata,1 Christos Chouaid,2 Katell Le Lay,3 Laura Luciani,3 Ceilidh McConnachie,4 James Gordon,5 Stéphane Roze1 1HEVA-HEOR, Lyon, 2Centre Hospitalier, Intercommunal de Créteil, Créteil, 3Boehringer Ingelheim, Paris, France; 4Ossian Health Economics and Communic...

Full description

Bibliographic Details
Main Authors: Pignata M, Chouaid C, Le Lay K, Luciani L, McConnachie C, Gordon J, Roze S
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
Cost
cost-effectiveness
afatinib
Lung cancer
Online Access:https://www.dovepress.com/evaluating-the-cost-effectiveness-of-afatinib-after-platinum-based-the-peer-reviewed-article-CEOR

Internet

https://www.dovepress.com/evaluating-the-cost-effectiveness-of-afatinib-after-platinum-based-the-peer-reviewed-article-CEOR

Similar Items